These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11145948)

  • 1. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor.
    Grabowski EF; Reininger AJ; Petteruti PG; Tsukurov O; Orkin RW
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):157-62. PubMed ID: 11145948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.
    Grabowski EF; Zuckerman DB; Nemerson Y
    Blood; 1993 Jun; 81(12):3265-70. PubMed ID: 8507863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
    Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
    Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro.
    Westmuckett AD; Lupu C; Roquefeuil S; Krausz T; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2474-82. PubMed ID: 11073855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
    Grabowski EF; Carter CA; Ingelfinger JR; Tsukurov O; Conroy N; Abbott WM; Orkin RW
    Pediatr Res; 1999 Dec; 46(6):742-7. PubMed ID: 10590033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
    Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC
    Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
    Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
    J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
    Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity.
    Ott I; Vukovich R; Schömig A; Neumann FJ
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):539-44. PubMed ID: 12960606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
    Nguyên P; Broussas M; Cornillet-Lefèbvre P; Potron G
    Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators.
    Ameri A; Kuppuswamy MN; Basu S; Bajaj SP
    Blood; 1992 Jun; 79(12):3219-26. PubMed ID: 1596565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells.
    Camera M; Giesen PL; Fallon J; Aufiero BM; Taubman M; Tremoli E; Nemerson Y
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):531-7. PubMed ID: 10073954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor-expressing tumor cells can bind to immobilized recombinant tissue factor pathway inhibitor under static and shear conditions in vitro.
    Che SP; DeLeonardis C; Shuler ML; Stokol T
    PLoS One; 2015; 10(4):e0123717. PubMed ID: 25849335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
    Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
    Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminar shear, but not orbital shear, has a synergistic effect with thrombin stimulation on tissue factor expression in human umbilical vein endothelial cells.
    Rochier A; Nixon A; Yamashita N; Abe R; Abe R; Madri JA; Sumpio BE
    J Vasc Surg; 2011 Aug; 54(2):480-8. PubMed ID: 21367569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells.
    Stavik B; Espada S; Cui XY; Iversen N; Holm S; Mowinkel MC; Halvorsen B; Skretting G; Sandset PM
    Biochim Biophys Acta; 2016 Apr; 1862(4):670-678. PubMed ID: 26826018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
    Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
    J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.